共 50 条
Wilson?s disease: overview
被引:20
|作者:
Lucena-Valera, Ana
[1
]
Ruz-Zafra, Pilar
[1
]
Ampuero, Javier
[1
,2
,3
,4
]
机构:
[1] Hosp Univ Virgen del Rocio, Dept Enfermedades Digest, Seville, Spain
[2] Inst Biomed Sevilla IBiS, Seville, Spain
[3] Univ Seville, Seville, Spain
[4] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源:
关键词:
Wilson?s disease;
Copper;
Ceruloplasmin;
ATP7B;
Liver disease;
Neurological disease;
URINARY COPPER EXCRETION;
EXCHANGEABLE COPPER;
DIAGNOSIS;
LIVER;
PENICILLAMINE;
GUIDELINES;
FEATURES;
MODEL;
D O I:
10.1016/j.medcli.2022.12.016
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Wilson's disease (WD) is an uncommon hereditary disorder caused by a deficiency in the ATP7B trans-porter. The protein codified by this gene facilitates the incorporation of the copper into ceruloplasmin. Therefore, WD accumulates copper primary in the liver and secondary in other organs, such as the cen-tral nervous system. It represents a wide spectrum of disease, ranging from being asymptomatic in some patients to promote an acute liver failure in others. The diagnosis requires a combination of clinical signs and symptoms, as well as some diagnostic tests such as the measurement of serum ceruloplasmin, the urinary excretion of copper, the liver biopsy or the genetic testing. The treatment must be maintained lifelong and includes some drugs such as chelating agents (penicillamine and trientine) and inhibitors of the copper absorption (zinc salts). Lastly, the liver transplant should be an option for patients with end-stage liver disease. (c) 2023 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:261 / 267
页数:7
相关论文